MedPath

南京海融制药有限公司

Ownership
-
Established
2015-07-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Bupivacaine Hydrochloride Injection

Product Name
盐酸布比卡因注射液
Approval Number
国药准字H20253665
Approval Date
Mar 18, 2025
NMPA

Bupivacaine Hydrochloride Injection

Product Name
盐酸布比卡因注射液
Approval Number
国药准字H20253664
Approval Date
Mar 18, 2025
NMPA

Calcitriol Injection

Product Name
骨化三醇注射液
Approval Number
国药准字H20249716
Approval Date
Dec 6, 2024
NMPA

Calcitriol Injection

Product Name
骨化三醇注射液
Approval Number
国药准字H20249682
Approval Date
Dec 6, 2024
NMPA

Phenylephrine Hydrochloride Injection

Product Name
盐酸去氧肾上腺素注射液
Approval Number
国药准字H20243723
Approval Date
May 15, 2024
NMPA

Phenylephrine Hydrochloride Injection

Product Name
盐酸去氧肾上腺素注射液
Approval Number
国药准字H20243722
Approval Date
May 15, 2024
NMPA

Calcitriol Soft Capsules

Product Name
骨化三醇软胶囊
Approval Number
国药准字H20247023
Approval Date
Jan 31, 2024
NMPA

Paricalcitol Injection

Product Name
帕立骨化醇注射液
Approval Number
国药准字H20234752
Approval Date
Dec 29, 2023
NMPA

Eldecalcitol Soft Capsules

Product Name
艾地骨化醇软胶囊
Approval Number
国药准字H20234465
Approval Date
Nov 7, 2023
NMPA

Eldecalcitol Soft Capsules

Product Name
艾地骨化醇软胶囊
Approval Number
国药准字H20234466
Approval Date
Nov 7, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.